サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1610888

自動体外式除細動器（AED）の世界市場 - 市場考察、競合情勢、市場予測（2030年）

Automated External Defibrillator (AED) - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
自動体外式除細動器（AED）の世界市場 - 市場考察、競合情勢、市場予測（2030年）
出版日: 2024年12月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の自動体外式除細動器（AED）の市場規模は、2024年～2030年の予測期間にCAGRで8.62%の成長が見込まれます。市場は主に、心房細動や冠動脈疾患（CAD）を含む心血管疾患などの慢性疾患の患者の増加や、主要企業による革新的な製品開発活動、老年人口の増加による大幅な市場成長を示しており、これらが2024年～2030年の予測期間に市場の全体的な成長を促進する見込みです。

自動体外式除細動器（AED）の市場力学

World Heart Report（2023年）が提供したデータによると、2021年、世界全体で5億人を超える人々が心血管疾患を抱えて生活しています。さらに、American Heart Association（2023年）が提供した最新データによると、2030年までに世界で1,200万人超が心房細動に罹患すると推定されています。British Heart FoundationのGlobal Heart & Circulatory Diseases Factsheet（2024年）によると、現在世界中で約2億人がCADとともに生活しています。

自動体外式除細動器（AED）は、心房細動やCADのような心血管系の疾患や状態を管理する上で極めて重要です。自動体外式除細動器（AED）は、突然の心停止に陥った人に電気ショックを与え、正常な心拍のリズムを回復させることができます。心臓のリズムが不規則になる心房細動の場合は、これを使用して心拍のリズムを正常な状態にリセットすることができます。CADが心停止を引き起こした場合、これらの装置は救命に役立ちます。その使用は、タイムリーな介入を提供し、重要な瞬間に蘇生が成功する可能性を高めることによって、生存率を向上させるのに役立ちます。

世界の規制機関による製品開発活動の活発化も、自動体外式除細動器（AED）市場成長に直面する見通しです。例えば2024年1月、Element Scienceは、突然の心停止のリスクがあり、長期的な植込みを行う資格がない、または行いたくない人に、よりウェアラブルな選択肢を提供するために設計されたパッチ除細動器について、欧州でCEマークを取得し、英国で承認を取得しました。

世界保健機関（WHO）が2021年に発表したデータによると、2015年～2050年に、60歳以上の高齢者は12%から22%に倍増し、2050年までに21億人に達します。さらに2030年までに、6人に1人が60歳以上の高齢者となります。世界の人々の高齢化に伴い、心疾患に罹患しやすい60歳以上の高齢者が大幅に増加する中、自動体外式除細動器（AED）は救急医療において重要な役割を果たしています。自動体外式除細動器（AED）は、突然の心停止の際に心拍のリズムを正常に戻すために使用されますが、このような心停止は加齢に伴う健康状態により高齢者に多く見られます。即座に救命介入を行うことで、高齢者の生存率と予後を大幅に改善することができるため、これらは高齢化社会における救急対応システムに不可欠な要素となっています。

したがって、上記のすべての要因が総体的に自動体外式除細動器（AED）市場全体の成長を促進します。

しかし、電極部位の火傷や皮膚の損傷を伴う、自動体外式除細動器（AED）による電気ショックなどは、自動体外式除細動器（AED）市場の成長にとっての課題となる可能性があります。

当レポートでは、世界の自動体外式除細動器（AED）市場について調査分析し、各地域の市場規模と予測、過去3年の製品/技術開発、市場の主要企業、将来の機会などの情報を提供しています。

目次

第1章 自動体外式除細動器（AED）市場レポートのイントロダクション

第2章 自動体外式除細動器（AED）市場のエグゼクティブサマリー

  • 市場の概要

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 自動体外式除細動器（AED）市場の主な要因の分析

  • 自動体外式除細動器（AED）市場の促進要因
    • 心血管疾患の増加
    • 製品開発活動の活発化
    • 生活習慣病の増加
    • 老年人口の増加
  • 自動体外式除細動器（AED）市場の抑制要因と課題
    • 電極部位の火傷や皮膚損傷を伴う、自動体外式除細動器（AED）による電気ショック
  • 自動体外式除細動器（AED）市場の機会
    • 遠隔医療プラットフォームや遠隔モニタリングシステムなどのデジタルヘルスソリューションとの統合
    • より正確な診断に関連するAIと機械学習の応用

第6章 自動体外式除細動器（AED）市場のポーターのファイブフォース分析

第7章 自動体外式除細動器（AED）市場の評価

  • 製品タイプ別
    • ウェアラブル
    • 非ウェアラブル
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • 在宅ケア環境
    • その他
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 自動体外式除細動器（AED）市場の企業と製品のプロファイル

  • Koninklijke Philips N.V.
  • ZOLL Medical Corporation
  • BPL Medical Technologies
  • Stryker
  • Mediana Co., Ltd
  • CU Medical System Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • SCHILLER
  • Bexen Cardio PLC.
  • Nihon Kohden Corporation
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • Progetti S.r.l.
  • Abbott
  • HEARTHERO
  • Kestra Medical Technologies, Inc.
  • Trivitron Healthcare
  • F. Amiitalia
  • Shanghai Huifeng Medical Instrument Co., Ltd
  • Metrax GmbH
  • Meditech Equipment Co ., Ltd

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Automated External Defibrillators Market in Global (2021-2030)
  • Table 3: Automated External Defibrillators Market in Global by Product Type (2021-2030)
  • Table 4: Automated External Defibrillators Market in Global by End-User (2021-2030)
  • Table 5: Automated External Defibrillators Market in Global by Geography (2021-2030)
  • Table 6: Automated External Defibrillators Market in North America (2021-2030)
  • Table 7: Automated External Defibrillators Market in the United States (2021-2030)
  • Table 8: Automated External Defibrillators Market in Canada (2021-2030)
  • Table 9: Automated External Defibrillators Market in Mexico (2021-2030)
  • Table 10: Automated External Defibrillators Market in Europe (2021-2030)
  • Table 11: Automated External Defibrillators Market in France (2021-2030)
  • Table 12: Automated External Defibrillators Market in Germany (2021-2030)
  • Table 13: Automated External Defibrillators Market in United Kingdom (2021-2030)
  • Table 14: Automated External Defibrillators Market in Italy (2021-2030)
  • Table 15: Automated External Defibrillators Market in Spain (2021-2030)
  • Table 16: Automated External Defibrillators Market in the Rest of Europe (2021-2030)
  • Table 17: Automated External Defibrillators Market in Asia-Pacific (2021-2030)
  • Table 18: Automated External Defibrillators Market in China (2021-2030)
  • Table 19: Automated External Defibrillators Market in Japan (2021-2030)
  • Table 20: Automated External Defibrillators Market in India (2021-2030)
  • Table 21: Automated External Defibrillators Market in Australia (2021-2030)
  • Table 22: Automated External Defibrillators Market in South Korea (2021-2030)
  • Table 23: Automated External Defibrillators Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Automated External Defibrillators Market in the Rest of the World (2021-2030)
  • Table 25: Automated External Defibrillators Market in the Middle East (2021-2030)
  • Table 26: Automated External Defibrillators Market in Africa (2021-2030)
  • Table 27: Automated External Defibrillators Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Automated External Defibrillators Market in Global (2021-2030)
  • Figure 3: Automated External Defibrillators Market in Global by Product Type (2021-2030)
  • Figure 4: Automated External Defibrillators Market in Global by End-User (2021-2030)
  • Figure 5: Automated External Defibrillators Market in Global by Geography (2021-2030)
  • Figure 6: Automated External Defibrillators Market in North America (2021-2030)
  • Figure 7: Automated External Defibrillators Market in the United States (2021-2030)
  • Figure 8: Automated External Defibrillators Market in Canada (2021-2030)
  • Figure 9: Automated External Defibrillators Market in Mexico (2021-2030)
  • Figure 10: Automated External Defibrillators Market in Europe (2021-2030)
  • Figure 11: Automated External Defibrillators Market in France (2021-2030)
  • Figure 12: Automated External Defibrillators Market in Germany (2021-2030)
  • Figure 13: Automated External Defibrillators Market in United Kingdom (2021-2030)
  • Figure 14: Automated External Defibrillators Market in Italy (2021-2030)
  • Figure 15: Automated External Defibrillators Market in Spain (2021-2030)
  • Figure 16: Automated External Defibrillators Market in the Rest of Europe (2021-2030)
  • Figure 17: Automated External Defibrillators Market in Asia-Pacific (2021-2030)
  • Figure 18: Automated External Defibrillators Market in China (2021-2030)
  • Figure 19: Automated External Defibrillators Market in Japan (2021-2030)
  • Figure 20: Automated External Defibrillators Market in India (2021-2030)
  • Figure 21: Automated External Defibrillators Market in Australia (2021-2030)
  • Figure 22: Automated External Defibrillators Market in South Korea (2021-2030)
  • Figure 23: Automated External Defibrillators Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Automated External Defibrillators Market in the Rest of the World (2021-2030)
  • Figure 25: Automated External Defibrillators Market in the Middle East (2021-2030)
  • Figure 26: Automated External Defibrillators Market in Africa (2021-2030)
  • Figure 27: Automated External Defibrillators Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0467

Automated External Defibrillators Market by Product Type (Wearable and Non-Wearable), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of cardiovascular disorders and the rising product developmental activities worldwide

The automated external defibrillators market is estimated to grow at 8.62% CAGR during the forecast period from 2024 to 2030. The automated external defibrillator market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the automated external defibrillators market during the forecast period from 2024 to 2030.

Automated External Defibrillators Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to the updated data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally. According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world.

Automated external defibrillators are crucial in managing cardiovascular diseases and conditions like atrial fibrillation and CAD. For individuals experiencing sudden cardiac arrest, automated external defibrillators can deliver an electric shock to restore a normal heart rhythm, which is vital in emergencies. In cases of atrial fibrillation, where the heart's rhythm becomes irregular, these can be used to reset the heart's rhythm to its normal state. These devices can be life-saving in instances where CAD leads to cardiac arrest. Their use helps improve survival rates by providing timely intervention and increasing the chances of successful resuscitation during critical moments.

Increased product developmental activities by regulatory bodies worldwide is also slated to witness market growth for automated external defibrillators. For example, in January 2024, Element Science received a CE mark in Europe and approval in the U.K. for its patch-based cardioverter defibrillator, designed to offer a more wearable option for individuals at risk of sudden cardiac arrest who may not qualify for or prefer not to have a long-term implant.

As per data provided by the World Health Organization 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. As the global population ages, with a significant increase in individuals over 60 years old, who are more susceptible to cardiac events, automated external defibrillators play a vital role in emergency medical care. They are used to restore normal heart rhythms in cases of sudden cardiac arrest, which is more common in older adults due to age-related health conditions. By providing immediate, life-saving intervention, these can significantly improve survival rates and outcomes for the elderly, making them an essential component of emergency response systems in aging societies.

Therefore, all the factors stated above collectively will drive the overall automated external defibrillator market growth.

However, electric shock delivered by automated external defibrillators associated with burns or skin damage at the electrode site, and others may prove to be challenging factors for the automated external defibrillators market growth.

Automated External Defibrillators Market Segment Analysis:

Automated External Defibrillators Market by Product Type (Wearable and Non-Wearable), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of automated external defibrillators, the wearable category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and various key features of wearable defibrillators that enhance their utility and effectiveness.

Wearable automated external defibrillators have gained widespread use as a critical safety measure for individuals at high risk of sudden cardiac arrest, particularly those who may not yet qualify for an implantable defibrillator or are awaiting surgery. Key features of these devices include real-time heart monitoring, which provides continuous surveillance without requiring any action from the user. They are equipped with voice and visual prompts that guide the user or bystanders through the defibrillation process, ensuring that the device is easy to operate even in high-stress situations. Also, these devices are designed to be lightweight and comfortable, allowing patients to go about their daily activities with minimal disruption.

Furthermore, technological advancements and product innovations taking place in the development of wearable automated external defibrillators are likely to propel the automated external defibrillators market growth. For instance, in August 2021, Kestra(TM) Medical Technologies, Inc. announced that the company received premarket approval from the U.S. Food and Drug Administration (FDA) for the ASSURE(R) Wearable Cardioverter Defibrillator system.

Therefore, the widespread uses and various key features of wearable defibrillators that enhance performance and usability are solidifying the impact on the growth of the overall automated external defibrillators market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall automated external defibrillators market:

Among all the regions, North America is expected to dominate the automated external defibrillators market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high prevalence of coronary artery disease, myocardial infarctions, and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the automated external defibrillators market in the North America region during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure among others. Some of the key risk factors associated with heart disease are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

Data from the Canadian Institute for Health Information (2024), stated that in 2022, 2.4 million Canadians were affected by heart disease. Automated External Defibrillators play a critical role in managing severe heart conditions such as CAD and myocardial infarction (heart attack). They are used to restore a normal heart rhythm during sudden cardiac arrest, a potential complication of these conditions. These devices can be found in various settings, including public spaces, hospitals, and emergency response kits. Their ability to provide immediate electrical shocks to the heart can significantly improve survival rates and outcomes in cardiac emergencies. In cases of heart disease, where patients may experience irregular heart rhythms or sudden cardiac arrest, automated external defibrillators are essential tools for prompt intervention and treatment.

Rising product developmental activities by regulatory bodies in the region will further boost the market for automated external defibrillators. For example, in January 2023, Avive Solutions, Inc., received the U.S. Food and Drug Administration (FDA) pre-market approval for its Avive AED(TM), a unique Automated External Defibrillator (AED).

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American automated external defibrillators market.

Automated External Defibrillators Market key players:

Some of the key market players operating in the automated external defibrillators market include Koninklijke Philips N.V., ZOLL Medical Corporation, BPL Medical Technologies, Stryker, Mediana Co., Ltd, CU Medical System Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd, SCHILLER, Bexen Cardio PLC., Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Co., Ltd., Progetti S.r.l., Abbott, HEARTHERO, Kestra Medical Technologies, Inc., Trivitron Healthcare, F. Amiitalia, Shanghai Huifeng Medical Instrument Co.,Ltd, Metrax GmbH, Meditech Equipment Co .,Ltd, and others.

Recent Developmental Activities in the Automated External Defibrillators Market:

  • In October 2023, Medtronic plc, received FDA approval for its Aurora EV-ICD(TM) MRI SureScan(TM) Extravascular Implantable Cardioverter-defibrillator and Epsila EV(TM) MRI SureScan(TM) defibrillation lead. These devices are designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
  • In June 2021, Rapid Response Revival (RRR) earned CE mark certification in Europe for their automated external defibrillator (AED), CellAED.

Key Takeaways from the Automated External Defibrillators Market Report Study

  • Market size analysis for current automated external defibrillators market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the automated external defibrillators market.
  • Various opportunities available for the other competitors in the automated external defibrillators market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current automated external defibrillators market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for automated external defibrillator market growth in the coming future?

Target Audience who can be benefited from this Automated External Defibrillators Market Report Study

  • Automated external defibrillators product providers
  • Research organizations and consulting companies
  • Automated external defibrillators-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in automated external defibrillators
  • Various end-users who want to know more about the automated external defibrillators market and the latest technological developments in the automated external defibrillators market.

Frequently Asked Questions for the Automated External Defibrillators Market:

1. What are Automated External Defibrillators?

Automated external defibrillators are medical devices used to deliver a controlled electric shock to the heart in cases of life-threatening cardiac arrhythmias, such as ventricular fibrillation or pulseless ventricular tachycardia. The purpose of the shock is to reset the heart's electrical activity, allowing it to reestablish a normal rhythm.

2. What is the market for Automated External Defibrillators?

The automated external defibrillators market is estimated to grow at 8.62% CAGR during the forecast period from 2024 to 2030.

3. What are the drivers for the Automated External Defibrillators market?

The automated external defibrillator market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the automated external defibrillators market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Automated External Defibrillators market?

Some of the key market players operating in automated external defibrillators include Koninklijke Philips N.V., ZOLL Medical Corporation, BPL Medical Technologies, Stryker, Mediana Co., Ltd, CU Medical System Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd, SCHILLER, Bexen Cardio PLC., Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Co., Ltd., Progetti S.r.l., Abbott, HEARTHERO, Kestra Medical Technologies, Inc., Trivitron Healthcare, F. Amiitalia, Shanghai Huifeng Medical Instrument Co.,Ltd, Metrax GmbH, Meditech Equipment Co .,Ltd, and others.

5. Which region has the highest share in the Automated External Defibrillators market?

North America is expected to dominate the overall automated external defibrillators market during the forecast period from 2024 to 2030. This can be attributed to several factors including high prevalence of coronary artery disease, myocardial infarctions, and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the automated external defibrillators market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Automated External Defibrillators Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Automated External Defibrillators Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Automated External Defibrillators Market Key Factors Analysis

  • 5.1. Automated External Defibrillators Market Drivers
    • 5.1.1. Increasing cases of cardiovascular disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Increasing prevalence of lifestyle disorders
    • 5.1.4. Rising geriatric population
  • 5.2. Automated External Defibrillators Market Restraints and Challenges
    • 5.2.1. Electric shock delivered by automated external defibrillators associated with burns or skin damage at the electrode site
  • 5.3. Automated External Defibrillators Market Opportunities
    • 5.3.1. Integration with digital health solutions, such as telemedicine platforms and remote monitoring systems
    • 5.3.2. Application of artificial intelligence and machine learning associated with more accurate diagnosis

6. Automated External Defibrillators Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Automated External Defibrillators Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Wearable
    • 7.1.2. Non-wearable
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Homecare Settings
    • 7.2.4. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Automated External Defibrillators Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Automated External Defibrillators Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.3. India Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Automated External Defibrillators Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Automated External Defibrillators Market Size in USD million (2021-2030)

8. Automated External Defibrillators Market Company and Product Profiles

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. ZOLL Medical Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. BPL Medical Technologies
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Stryker
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Mediana Co., Ltd
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. CU Medical System Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Shenzhen Mindray Bio-Medical Electronics Co. Ltd
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. SCHILLER
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Bexen Cardio PLC.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Nihon Kohden Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Shenzhen Comen Medical Instruments Co., Ltd.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Progetti S.r.l.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Abbott
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. HEARTHERO
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Kestra Medical Technologies, Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Trivitron Healthcare
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. F. Amiitalia
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Shanghai Huifeng Medical Instrument Co.,Ltd
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Metrax GmbH
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Meditech Equipment Co .,Ltd
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us